IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan
5/9/2013 9:31:10 AM
More...
|
IntelGenx Corp. Submits New Drug Application for Anti-Migraine VersaFilm™
3/27/2013 11:02:11 AM
More...
|
IntelGenx Corp. to Present at Roth Capital Partners 25th Annual Growth Stock Conference
3/18/2013 12:39:37 PM
More...
|
IntelGenx Corp. Appoints Rajiv Khosla RPh, PhD, MBA
12/11/2012 10:07:47 AM
More...
|
IntelGenx Corp. Grants Stock Options
12/7/2012 9:19:57 AM
More...
|
IntelGenx Corp. Reports Third Quarter 2012 Results and Highlights Recent Developments
11/13/2012 8:30:15 AM
More...
|
IntelGenx Corp. Announces Commercial Launch of Forfivo XL™ in USA
10/9/2012 9:28:35 AM
More...
|
IntelGenx Corp. to Present at the 2012 Aegis Healthcare Conference in Las Vegas
9/27/2012 9:52:33 AM
More...
|
IntelGenx Corp. Upgrades to OTCQX(R), the Highest Tier of the OTC Market, on June 14, 2012
6/14/2012 10:10:39 AM
More...
|
IntelGenx Corp. Achieves Positive Pivotal Study Results for Bioequivalent Anti-Migraine VersaFilm Formulation of Maxalt-MLT(R)
5/29/2012 9:46:50 AM
More...
|
|